TABLE 2.
Variables | Univariate analysis | Multivariate analysis | ||||
---|---|---|---|---|---|---|
HR | 95% CI | P | HR | 95% CI | P | |
BCAS3high vs BCAS3low expression | 12.827 | 4.577‐35.948 | <.001 | 11.979 | 4.132‐34.725 | <.001 |
Age | 0.755 | 0.414‐1.375 | .358 | 0.740 | 0.387‐1.414 | .362 |
Location | 0.817 | 0.449‐1.489 | .510 | 0.927 | 0.481‐1.789 | .822 |
Tumour size | 1.828 | 1.003‐3.331 | .049 | 1.294 | 0.674‐2.483 | .438 |
Oestrogen receptor | 0.766 | 0.420‐1.399 | .387 | 0.785 | 0.354‐1.738 | .550 |
Progesterone receptor | 0.567 | 2.296‐1.088 | .088 | 0.740 | 0.316‐1.732 | .488 |
HER2 | 1.959 | 0.270‐14.239 | .506 | 1.496 | 1.980‐11.334 | .697 |
Grade II vs Grade III | 1.180 | 0.648‐2.150 | .588 | 0.573 | 0.294‐1.115 | .101 |
stage I vs stage II vs stage III | 2.100 | 1.286‐3.428 | .003 | 1.308 | 0.793‐2.159 | .293 |
Abbreviations: 95%CI, 95% confidence interval; OS, overall survival.
P <0.05 was considered statistically significant.